or Try an Advanced Search...

    Technical Analysis for GSD - Devonian Health Group Inc

    Grade Last Price % Change Price Change
    F 0.135 0.00% 0.000
    GSD closed up 22.73 percent on Wednesday, October 30, 2024, on 29 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical GSD trend table...
    Date Alert Name Type % Chg
    Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    MACD Bearish Signal Line Cross Bearish 22.73%
    New 52 Week Closing Low Bearish 22.73%
    Expansion Breakdown Bearish Swing Setup 22.73%
    Reversal New Lows Setup Bearish Swing Setup 22.73%
    Older End-of-Day Signals for GSD ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day 3 days ago
    Gap Up Partially Closed 3 days ago
    Gapped Up (Partial) 3 days ago
    Up 1 ATR 3 days ago
    Rose Above Lower Bollinger Band 3 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    GSD Chart by TradingView
    Basic chart:

    Profile

    Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, which is in Phase IIa clinical trials for the treatment of ulcerative colitis and atopic dermatitis. The company also develops value-added products for dermo-cosmetics, and distributes pharmaceutical products. In addition, it acquires drug and health product licenses. Devonian Health Group Inc. has a strategic alliance with CannTx Life Sciences Inc. for the development of cannabinoid-based pharmaceutical drugs. The company was incorporated in 2013 and is headquartered in Québec, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Health Pharma Pharmaceutical Clinic Drug Science Drugs Life Sciences Pharmaceutical Products Health Sciences Clinical Trial Pharmaceutical Industry Cannabinoid Atopic Dermatitis Medication Ulcer Ulcerative Colitis Cosmetics Pharmaceutical Drugs Pharmaceutical Sciences Colitis

    Is GSD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.68
    52 Week Low 0.075
    Average Volume 20,485
    200-Day Moving Average 0.232
    50-Day Moving Average 0.171
    20-Day Moving Average 0.153
    10-Day Moving Average 0.151
    Average True Range 0.018
    RSI (14) 43.50
    ADX 15.18
    +DI 26.598
    -DI 55.736
    Chandelier Exit (Long, 3 ATRs) 0.136
    Chandelier Exit (Short, 3 ATRs) 0.129
    Upper Bollinger Bands 0.177
    Lower Bollinger Band 0.128
    Percent B (%b) 0.14
    BandWidth 32.199
    MACD Line -0.008
    MACD Signal Line -0.005
    MACD Histogram -0.0022
    Fundamentals Value
    Market Cap 8.48 Million
    Num Shares 62.8 Million
    EPS -0.05
    Price-to-Earnings (P/E) Ratio -2.81
    Price-to-Sales 3.69
    Price-to-Book 1.16
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.135
    Resistance 3 (R3) 0.135 0.135 0.135
    Resistance 2 (R2) 0.135 0.135 0.135 0.135
    Resistance 1 (R1) 0.135 0.135 0.135 0.135 0.135
    Pivot Point 0.135 0.135 0.135 0.135 0.135
    Support 1 (S1) 0.135 0.135 0.135 0.135 0.135
    Support 2 (S2) 0.135 0.135 0.135 0.135
    Support 3 (S3) 0.135 0.135 0.135
    Support 4 (S4) 0.135